Design, creation and in vitro testing of a reduced immunogenicity humanized anti-CD25 monoclonal antibody that retains functional activity.

Saved in:
Bibliographic Details
Title: Design, creation and in vitro testing of a reduced immunogenicity humanized anti-CD25 monoclonal antibody that retains functional activity.
Authors: Stickler M; AbbVie, Redwood City, CA, USA., Reddy A; AbbVie, Redwood City, CA, USA., Xiong JM; AbbVie, Redwood City, CA, USA., Wong MH; Formerly of AbbVie, Redwood City, CA, USA., Akamatsu Y; AbbVie, Redwood City, CA, USA., Hinton PR; Formerly of AbbVie, Redwood City, CA, USA.; IGM Biosciences, Mountain View, CA, USA., Harding FA; Formerly of AbbVie, Redwood City, CA, USA.
Source: Protein engineering, design & selection : PEDS [Protein Eng Des Sel] 2019 Dec 31; Vol. 32 (12), pp. 543-554.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101186484 Publication Model: Print Cited Medium: Internet ISSN: 1741-0134 (Electronic) Linking ISSN: 17410126 NLM ISO Abbreviation: Protein Eng Des Sel Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1741-0134
DOI:10.1093/protein/gzaa017